PrimeRFP SCOUT · Federal Contract Recompete Brief

15F06723F0000873Quadrivalent FLU vaccine in prefilled syringes — Glaxosmithkline LLC

Glaxosmithkline LLC holds $3.0B across 194 federal awards, concentrated at Department of Health and Human Services (HHS). This PIID sits alongside 5 related awards under parent 36F79722D0178. The prior award was single-bid — competitive dynamics may favor a challenge. PoP ended Jul 1, 2023 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Division 1200

Awarding office

Glaxosmithkline LLC

Recipient

Jul 1, 2023

PoP end

$251K

Obligated

$251K

Potential

325412

NAICS

6515

PSC

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Glaxosmithkline LLC — $90

Contract facts

Federal

Contract number15F06723F0000873

Also listed as36F79722D0178-15F06723F0000873

AgencyDivision 1200

Awarding officeDivision 1200

Awarding agencyDepartment of Justice (DOJ)

Funding agencyDepartment of Justice (DOJ)

IncumbentGlaxosmithkline LLC

CAGE667E9

UEIFRHTPHMZMX47

NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6515

Parent IDIQ / IDV36F79722D0178

Place of performanceDURHAM NC

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition

PoP startMay 24, 2023

PoP end (current)Jul 1, 2023

PoP end (w/ options)Sep 30, 2023

Obligated$251K

Current value$251K

Potential value$251K

QUADRIVALENT FLU VACCINE IN PREFILLED SYRINGES. is a federal award for Division 1200 held by Glaxosmithkline LLC. Estimated value $251K ($251K obligated). Current period of performance ends Jul 1, 2023 (potential Sep 30, 2023). Last award drew 1 bidder. Place of performance: DURHAM NC.

QUADRIVALENT FLU VACCINE IN PREFILLED SYRINGES.

Recompete timing

Public

● Past PoP end (1147 days ago)

Current PoP ended Jul 1, 2023 (1147 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Glaxosmithkline LLC — $3.0B obligated across 194 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).

% of firm-wide obligated ($3.0B) · all agencies

Department of Health and Human Services (HHS)$3.0B · 100%Department of Defense (DOD)$1.7M · 0%Department of Veterans Affairs (VA)$1.5M · 0%Department of State (DOS)$1.2M · 0%

Open full company profile →

Related awards

Same parent · incumbent

75A50125F61019

FILL/FINISH DOD AS03 ADJUVANT CLIN 1006E

$491K

Aug 30, 2026

75A50126F61020

TWO-WAY IMMUNOGENICITY TESTING ON EXISTING CLINICAL TRIAL SERA TO IMMUNOGENICITY SUPERIOR…

$493K

Oct 29, 2026

15F06724F0001366

GSK TRAVEL VACCINES

$115K

Dec 31, 2026

15F06726F0000234

GSK VACCINES TERMS AND CONDITIONS REMAIN THE SAME - BPA 15F06722A0000187

$105K

Dec 31, 2026

75A50124F61014

THIS TASK ORDER ESTABLISHES SERVICES FOR H5 PANDEMIC READINESS FOR ACQUISITION OF MEDICAL …

$18.4M

Feb 21, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 15F06723F0000873?

15F06723F0000873 (Quadrivalent FLU vaccine in prefilled syringes) is a Division 1200 award with a potential value of $251K, currently held by Glaxosmithkline LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 15F06723F0000873?

Division 1200 awarded 15F06723F0000873 to Glaxosmithkline LLC (potential $251K).

Who is the incumbent on 15F06723F0000873?

Glaxosmithkline LLC is the incumbent with $3.0B across 194 related awards in SCOUT’s public footprint. The current period of performance ends Jul 1, 2023.

When does Glaxosmithkline LLC’s 15F06723F0000873 come up for recompete?

SCOUT tracks a period-of-performance end of Jul 1, 2023. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Aug 19, 2026 · refreshed monthlyLatest procurement action May 19, 2023